Facial pain and drugs of ingredients of atorvastatin calcium - a phase IV clinical study of FDA data
Facial pain is found among people who take drugs with ingredients of atorvastatin calcium, especially for people who are female, 60+ old , have been taking the drugs for 1 - 2 years. This phase IV clinical study is created by eHealthMe based on reports of 494,866 people who have side effects when taking drugs with ingredients of atorvastatin calcium from the FDA, and is updated regularly.
Drug(s) considered in the study (i.e. both brand name and generic drugs): Atorvastatin calcium, Lipitor.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
494,866 people reported to have side effects when taking drugs with ingredients of atorvastatin calcium.
Among them, 405 people (0.08%) have Facial pain
What is Facial pain?
Facial pain is found to be associated with 1,970 drugs and 1,292 conditions by eHealthMe.
Number of reports submitted per year:
Time on drugs with ingredients of atorvastatin calcium when people have Facial pain *:
- < 1 month: 26.67 %
- 1 - 6 months: 26.67 %
- 6 - 12 months: 13.33 %
- 1 - 2 years: 33.33 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Gender of people who have Facial pain when taking drugs with ingredients of atorvastatin calcium *:
- female: 61.68 %
- male: 38.32 %
Age of people who have Facial pain when taking drugs with ingredients of atorvastatin calcium *:
- 0-1: 0.0 %
- 2-9: 1.02 %
- 10-19: 0.34 %
- 20-29: 0.34 %
- 30-39: 2.39 %
- 40-49: 12.29 %
- 50-59: 17.06 %
- 60+: 66.55 %
Conditions people have *:
- Osteoporosis (bones weak and more likely to break): 32 people, 7.90%
- Pain: 26 people, 6.42%
- Breast Cancer Metastatic: 18 people, 4.44%
- Muscle Spasms (muscle contraction): 17 people, 4.20%
- Depression: 17 people, 4.20%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 17 people, 4.20%
- Pain In Jaw: 16 people, 3.95%
- Hypersensitivity: 16 people, 3.95%
- Ill-Defined Disorder: 15 people, 3.70%
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 15 people, 3.70%
Other drugs people take *:
- Zometa: 109 people, 26.91%
- Aspirin: 75 people, 18.52%
- Prevacid: 62 people, 15.31%
- Levaquin: 58 people, 14.32%
- Lorazepam: 50 people, 12.35%
- Neurontin: 49 people, 12.10%
- Hydrochlorothiazide: 46 people, 11.36%
- Folic Acid: 46 people, 11.36%
- Toprol-Xl: 42 people, 10.37%
- Aredia: 41 people, 10.12%
Other side effects people have besides Facial pain *:
- Headache (pain in head): 132 people, 32.59%
- Pain: 121 people, 29.88%
- Pain In Jaw: 119 people, 29.38%
- Back Pain: 119 people, 29.38%
- Breathing Difficulty: 105 people, 25.93%
- Dizziness: 101 people, 24.94%
- Stress And Anxiety: 99 people, 24.44%
- Pain In Extremity: 94 people, 23.21%
- Osteonecrosis Of Jaw (death of bone of jaw): 87 people, 21.48%
- Osteomyelitis (infection of bone): 76 people, 18.77%
* Approximation only. Some reports may have incomplete information.
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Proti? D, Balti? S, Stupar N, Pavlov-Dolijanovi? S, Mugo?a S, Todorovi? Z, "A case of myositis with immunological background associated with statin use", Open Medicine, 2014 Oct .
- Goldie MP, "Atorvastatin: a new treatment for periodontal disease?", , 2012 Jan .
Drugs with ingredients of atorvastatin calcium, their effectiveness, alternatives and more:
How the study uses the data?
The study uses data from the FDA. It is based on atorvastatin calcium. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Myrbetriq and Chantix drug interaction - now
- Methocarbamol and Cardiac Failure - 13 seconds ago
- Rytary and Compulsions - 13 seconds ago
- Wellbutrin vs. Clorazepate Dipotassium - 28 seconds ago
- Increlex and Gabapentin drug interaction - 49 seconds ago
- Green Tea and Headache - 52 seconds ago
- Carboplatin and Atrophic Vulvovaginitis - 55 seconds ago
- Sodium Chloride and Lipase Increased - a minute ago
- Doxycycline and Fractured Ischium - a minute ago
- Multivitamin and Serzone drug interaction - a minute ago